| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [602] [603] [604] 605 [606] [607] [608] [609] Next Page Last Page Total 77072 items, Total 3083 Page Goto
| 2A-9025160 |
4-Aminobenzo-2,1,3-thiadiazole |
767-64-6 |
|
98.00% |
Inquiry |
| 2A-9025161 |
6-Bromopurine |
767-69-1 |
|
98.00% |
Inquiry |
| 2A-9025162 |
1-Phenyl-2-propen-1-one |
768-03-6 |
|
98.00% |
Inquiry |
| 2A-9025163 |
Pyrazinoic acid hydrazide |
768-05-8 |
|
98.00% |
Inquiry |
| 2A-9025164 |
5-Bromobenzothiazole |
768-11-6 |
|
98.00% |
Inquiry |
| 2A-9025165 |
5-Nitro-2-norbornene |
768-16-1 |
|
98.00% |
Inquiry |
| 2A-9025166 |
Indene oxide |
768-22-9 |
|
98.00% |
Inquiry |
| 2A-9025167 |
Phenyltrimethylsilane |
768-32-1 |
|
98.00% |
Inquiry |
| 2A-9025168 |
Chlorodimethylphenylsilane |
768-33-2 |
|
98.00% |
Inquiry |
| 2A-9025169 |
3-Fluorophenylboronic acid |
768-35-4 |
|
98.00% |
Inquiry |
| 2A-9025170 |
6-Ethoxy-2-pyridinamine |
768-42-3 |
|
98.00% |
Inquiry |
| 2A-9025171 |
N-Isopropylaniline |
768-52-5 |
|
98.00% |
Inquiry |
| 2A-9025172 |
4-Phenyl-1-butene |
768-56-9 |
|
98.00% |
Inquiry |
| 2A-9025173 |
4-Ethynylanisole |
768-60-5 |
|
98.00% |
Inquiry |
| 2A-9025174 |
2,2,6,6-Tetramethylpiperidine |
768-66-1 |
|
99.00% |
Inquiry |
| 2A-9025175 |
3-Ethynylanisole |
768-70-7 |
|
98.00% |
Inquiry |
| 2A-9025176 |
1-Bromoadamantane |
768-90-1 |
|
98.00% |
Inquiry |
| 2A-9025177 |
1-Methyladamantane |
768-91-2 |
|
98.00% |
Inquiry |
| 2A-9025178 |
Amantadine |
768-94-5 |
|
98.00% |
Inquiry |
| 2A-9025179 |
10,11-Dihydro-N-(2-hydroxyethyl)-N-methyl-5H-pyrido[2,3-c][2]benzazepine-10-carboxamide |
107-15-0 |
C17H19N3O2 |
98.00% |
Inquiry |
| 2A-9025180 |
2-Fluoro-6-nitrotoluene |
769-10-8 |
|
98.00% |
Inquiry |
| 2A-9025181 |
5-Amino-4-bromobenzothiazole |
769-19-7 |
|
98.00% |
Inquiry |
| 2A-9025182 |
3-Cyano-4,6-dimethyl-2-hydroxypyridine |
769-28-8 |
|
98.00% |
Inquiry |
| 2A-9025183 |
2,3,5,6-Tetrafluorophenol |
769-39-1 |
|
98.00% |
Inquiry |
| 2A-9025184 |
1,3-Dimethylbarbituric acid |
769-42-6 |
|
98.00% |
Inquiry |
| |
|
|
|
